Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / June / EGS Leaders Chart the Future of Glaucoma Care
Glaucoma Interview Voices in the Community

EGS Leaders Chart the Future of Glaucoma Care

Incoming and outgoing EGS presidents discuss the technologies, challenges, and priorities shaping the future of glaucoma care

By Julian Upton 6/23/2026 5 min read

Share

  • Full Article
  • Summary
  • Listen
  • Report
  • Quiz
  • Poll
  • Top Institutions

Clinical Report: EGS Leaders Chart the Future of Glaucoma Care

Overview

The European Glaucoma Society (EGS) emphasizes the integration of innovation and tradition in glaucoma care, focusing on artificial intelligence and digital technologies.

Background

The management of glaucoma is evolving, with increasing patient numbers and limited resources posing significant challenges. The EGS plays a crucial role in uniting various stakeholders in the glaucoma community to address these issues.

Data Highlights

No numerical data provided in the source material.

Key Findings

  • EGS has published the 6th Edition of its Guidelines, emphasizing innovation and education.
  • Artificial intelligence is a focal point for EGS, with discussions on its potential and limitations in glaucoma care.
  • Digital technologies are seen as a means to enhance access to glaucoma services across diverse healthcare systems in Europe.
  • Trabeculectomy remains a core component of glaucoma training despite the rise of new procedures.
  • EGS actively supports surgical education through dedicated training resources and courses.

Clinical Implications

Healthcare professionals should consider the discussions on emerging technologies like AI and telemedicine in their practice.

Conclusion

The EGS aims to advance glaucoma care through a combination of innovation and adherence to established practices.

Related Resources & Content

  1. European Glaucoma Society - Terminology and guidelines for glaucoma, 6th Edition - PubMed, 2025 -- Key Innovations
  2. Primary Open-Angle Glaucoma Preferred Practice Pattern® - Ophthalmology, 2025-2026 -- Diagnosis and Treatment Guidelines
  3. World Glaucoma Association » Consensus 12, 2025 -- Advances in Angle-Closure Disease
  4. Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial - ScienceDirect, 2023 -- Six-Year Results
  5. optometric management — The Evolving Glaucoma Toolbox
  6. glaucoma physician — Women in Glaucoma: Letter From the Editor
  7. glaucoma physician — A New Challenge—and Opportunity—in Glaucoma
  8. Glaucoma Physician — The Future of Glaucoma Care: Protecting the Optic Nerve
  9. The Evolving Glaucoma Toolbox
  10. Women in Glaucoma: Letter From the Editor
  11. A New Challenge—and Opportunity—in Glaucoma
  12. European Glaucoma Society - Terminology and guidelines for glaucoma, 6th Edition - PubMed
  13. Primary Open-Angle Glaucoma Preferred Practice Pattern® - Ophthalmology
  14. World Glaucoma Association » Consensus 12
  15. Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: Six-Year Results of Primary Selective Laser Trabeculoplasty versus Eye Drops for the Treatment of Glaucoma and Ocular Hypertension - ScienceDirect
  16. Randomized Noninferiority Trial of Direct Selective Laser Trabeculoplasty in Open-Angle Glaucoma and Ocular Hypertension
  17. Advancing glaucoma care: What's new in the 6th edition of the European Glaucoma Society guidelines
  18. Efficacy and safety of PreserFlo MicroShunt versus trabeculectomy in glaucoma patients: a systematic review, meta-analysis, and meta-regression of clinical outcomes and key covariates - PMC
  19. Six-Month Outcomes from a Prospective, Randomized Study of iStent infinite Versus Hydrus in Open-Angle Glaucoma: The INTEGRITY Study | Ophthalmology and Therapy | Springer Nature Link

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: